iScience (Jul 2023)

TRIAC disrupts cerebral thyroid hormone action via negative feedback and heterogenous distribution among organs

  • Ichiro Yamauchi,
  • Takuro Hakata,
  • Yohei Ueda,
  • Taku Sugawa,
  • Ryo Omagari,
  • Yasuo Teramoto,
  • Shoji F. Nakayama,
  • Daisuke Nakajima,
  • Takuya Kubo,
  • Nobuya Inagaki

Journal volume & issue
Vol. 26, no. 7
p. 107135

Abstract

Read online

Summary: As 3,3′,5-triiodothyroacetic acid (TRIAC), a metabolite of thyroid hormones (THs), was previously detected in sewage effluent, we aimed to investigate exogenous TRIAC’s potential for endocrine disruption. We administered either TRIAC or 3,3′,5-triiodo-L-thyronine (LT3) to euthyroid mice and 6-propyl-2-thiouracil-induced hypothyroid mice. In hypothyroid mice, TRIAC administration suppressed the hypothalamus-pituitary-thyroid (HPT) axis and upregulated TH-responsive genes in the pituitary gland, the liver, and the heart. We observed that, unlike LT3, TRIAC administration did not upregulate cerebral TH-responsive genes. Measurement of TRIAC contents suggested that TRIAC was not efficiently trafficked into the cerebrum. By analyzing euthyroid mice, we found that cerebral TRIAC content did not increase despite TRIAC administration at higher concentrations, whereas serum levels and cerebral contents of THs were substantially decreased. Disruption by TRIAC is due to the additive effects of circulating endogenous THs being depleted via a negative feedback loop involving the HPT axis and heterogeneous distribution of TRIAC among different organs.

Keywords